secwatch.observer — SEC 8-K summary
======================================

Issuer:     Structure Therapeutics Inc. (GPCR)
CIK:        0001888886
Form:       8-K
Filed at:   2024-06-27T23:59:59+00:00
Accession:  0001104659-24-075724
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Structure Therapeutics elects Sharon Tetlow to board; Ted Love joins audit committee
--------------------------------------------------------------------------------

- Sharon Tetlow elected as Class I director for 3-year term with 117.2M votes for, 12.6M against.
- Shareholders ratified Ernst & Young as independent auditor for FY2024 (129.9M for, 32k against).
- Ted W. Love, M.D. appointed to Audit Committee effective June 25, 2024.
- Audit Committee now consists of Sharon Tetlow, Eric Dobmeier, and Dr. Love.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1888886/000110465924075724/0001104659-24-075724-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1888886/000110465924075724/tm2418268d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-075724

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer